Clinical trial
Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
NCT00467584 · Mayo Clinic, Other · Terminated
Key facts
| NCT number | NCT00467584 |
|---|---|
| Title | Aspirin for Treatment of Multiple Sclerosis-Related Fatigue |
| Official title | Aspirin for Treatment of Multiple Sclerosis-Related Fatigue |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Multiple Sclerosis Society |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Fatigue |
| Intervention type | Drug |
| Interventions | High Dose Aspirin (1300 mg/day), Low Dose Aspirin (162 mg/day), Placebo |
| Enrollment | 62 |
| Start date | Jul 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Apr 30, 2007 |
| Last update posted | May 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: